Transplant Diagnostics Market | Expected to grow at a CAGR of 7.9%| By The Insight Partners

Transplant Diagnostics Market to 2027 – Global Analysis and Forecasts by Product & Services, Type, Technology, Application, and End User’. The global transplant diagnostics market is expected to reach US$ 1,542.89 Mn in 2027 from US$ 789.88 Mn in 2018. The market is estimated to grow with a CAGR of 7.9% from 2019-2027. The report highlights the trends prevalent in the global transplant diagnostics market and the factors driving the market along with those that act as deterrents to its growth.

The major players operating in the transplant diagnostics market include, Thermo Fisher Scientific Inc., Abbott, Illumina, Inc., F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., bioMérieux SA, QIAGEN, Hologic Inc., Luminex Corporation, and Omixon Inc.

To get a sample copy of the report along with the table of contents, Statistics @ https://www.theinsightpartners.com/sample/TIPRE00003076/?utm_source=OpenPR&utm_medium=10291

Product launches have been an essential strategy adopted by the industry players in the transplant diagnostics market. For instance, during April, 2018, Qiagen launched QIAstat-Dxâ in Europe. The product launched has played an important role in oncology or transplantation patients and has led to improved treatment decisions. It has also enabled the company to strengthen its presence in Europe region. These developments have helped the company in strengthening its existing product offering in the market, hence assuring a strong presence in the market.

The report segments the global transplant diagnostics market as follows:

– By Product & Services

Instruments
Reagents & Consumables
Software & Service

– By Type

Solid Organ Transplantation
Lung Transplantation
Liver Transplantation
Kidney Transplantation
Heart Transplantation
Other Solid Organ Transplantations
Soft Tissue Transplantation
Stem Cell Transplantation

– By Technology

Molecular Assays
Sequencing-Based Molecular Assays
Next-Generation Sequencing
Sanger Sequencing
Other Sequencing-Based Molecular Assays
PCR-Based Molecular Assays
Real-Time PCR
Sequence-Specific Primer-PCR
Other PCR-Based Molecular Assays
Non-Molecular Assays

– By Application

Diagnostic Applications
Pre-Transplantation Diagnostics
Post-Transplantation Diagnostics
Research Applications

– By End User

Hospitals & Transplant Centers
Research Laboratories & Academic Institutes
Independent Reference Laboratories

The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out and delayed or prolonged equipment procurement.

Drivers:

The market for transplant diagnostics is expected to grow due to factors such as, rising prevalence of cardiovascular diseases, significant growth of biotechnology industries, rising need for the organ transplantation and rising cell based research activities. In addition, the opportunities being offered from emerging nations is likely to have a positive impact on the growth of the market in the coming years.

Place an Order to Purchase Full Copy of this Report @ https://www.theinsightpartners.com/sample/TIPRE00003076/?utm_source=OpenPR&utm_medium=10291

Contact us:

Call: + 1-646-491-9876
Email: sales@theinsightpartners.com

About us:

The Insight Partners is a one-stop industry research provider for actionable information. We help our clients find solutions to their research needs through our syndicated and consultative research services. We are a specialist in technology, healthcare, manufacturing, automotive and defense, food and beverage, chemicals and materials, semiconductors, etc.

This release was published on openPR.